Clinical oncology最新文献

筛选
英文 中文
RCR meetings 软的会议
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-05-17 DOI: 10.1016/S0936-6555(25)00125-6
{"title":"RCR meetings","authors":"","doi":"10.1016/S0936-6555(25)00125-6","DOIUrl":"10.1016/S0936-6555(25)00125-6","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"42 ","pages":"Article 103870"},"PeriodicalIF":3.2,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144070706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paid MBP advert Advanced Educational Supervisor 210x280_01 付费MBP广告高级教育主管210x280_01
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-05-17 DOI: 10.1016/j.clon.2025.103876
{"title":"Paid MBP advert Advanced Educational Supervisor 210x280_01","authors":"","doi":"10.1016/j.clon.2025.103876","DOIUrl":"10.1016/j.clon.2025.103876","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"42 ","pages":"Article 103876"},"PeriodicalIF":3.2,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144070707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OncoFlash - Research Updates in a Flash! (June 2025) OncoFlash -研究更新在一个闪光!(2025年6月)
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-28 DOI: 10.1016/j.clon.2025.103858
C.W. Bleaney , C. Crockett
{"title":"OncoFlash - Research Updates in a Flash! (June 2025)","authors":"C.W. Bleaney , C. Crockett","doi":"10.1016/j.clon.2025.103858","DOIUrl":"10.1016/j.clon.2025.103858","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"42 ","pages":"Article 103858"},"PeriodicalIF":3.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143903908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employing Digital Health for the Follow-up and Monitoring of Patients Undergoing Anticancer Treatment: First Results of Satelia®Onco on Patient Satisfaction and Recommendations of Use in France 采用数字健康对接受抗癌治疗的患者进行随访和监测:Satelia®Onco在法国对患者满意度的初步结果和使用建议
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-26 DOI: 10.1016/j.clon.2025.103856
M. Zysman , A. Creisson , G. Ghrenassia , S. Nisse-Durgeat , A. Boyer , M. Matranga , C. Bedel , N. Pages , J. Ducray
{"title":"Employing Digital Health for the Follow-up and Monitoring of Patients Undergoing Anticancer Treatment: First Results of Satelia®Onco on Patient Satisfaction and Recommendations of Use in France","authors":"M. Zysman ,&nbsp;A. Creisson ,&nbsp;G. Ghrenassia ,&nbsp;S. Nisse-Durgeat ,&nbsp;A. Boyer ,&nbsp;M. Matranga ,&nbsp;C. Bedel ,&nbsp;N. Pages ,&nbsp;J. Ducray","doi":"10.1016/j.clon.2025.103856","DOIUrl":"10.1016/j.clon.2025.103856","url":null,"abstract":"<div><h3>Aims</h3><div>Telemedicine involves the use of information communication technologies and aims to support disease management, enhance treatment adherence, and improve patients’ quality of life (QoL). Despite its growing advantages, many challenges persist in its widespread adoption, which may be influenced by the health status and digital literacy of users. The objective of this study was to explore patient satisfaction with a web application used for the monitoring and follow-up of anticancer treatment.</div></div><div><h3><em>Material and methods</em></h3><div>A descriptive, multicentric, survey-based study was conducted with adult patients undergoing treatment in two oncology centres in France from October 2, 2023 to December 11, 2023. The online survey included 15 items covering the perceived usefulness, ease of use, and impact on QoL of a telemedicine solution used to monitor the side effects of anticancer treatment. Analysis was stratified by cancer type, duration of use, and age group.</div></div><div><h3><em>Results</em></h3><div>A total of 104 patients participated in the study (response rate: 33.0%). Most patients were female (64.4%), aged 46–65 years (42.3%), and were receiving treatment for lung cancer (50.0%) or breast cancer (39.4%). Remote monitoring was predominantly used for less than three months (39.4%), followed by more than six months (34.6%). Patient satisfaction and recommendation rates were high across age groups, cancer type, and durations of use (82.7%, respectively). Patients with breast cancer (82.9%) and lung cancer (82.7%) reported being absolutely satisfied. Positive feedback encompassed ease of access, comprehension of follow-up questions, and perceived usefulness. Older patients reported slightly lower scores for ease of use and improvement in QoL.</div></div><div><h3><em>Conclusion</em></h3><div>To our knowledge, these findings are among the first preliminary results concerning patient satisfaction for telemedicine use to monitor the side effects of anticancer treatment in clinical practice settings in France.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"43 ","pages":"Article 103856"},"PeriodicalIF":3.2,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144069175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-evaluating Adjuvant Therapy in Early-Stage Breast Cancer: Insights and Limitations From a Subtype Analysis 重新评估早期乳腺癌的辅助治疗:来自亚型分析的见解和局限性
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-18 DOI: 10.1016/j.clon.2025.103848
Q. Xu , Y. Gao
{"title":"Re-evaluating Adjuvant Therapy in Early-Stage Breast Cancer: Insights and Limitations From a Subtype Analysis","authors":"Q. Xu ,&nbsp;Y. Gao","doi":"10.1016/j.clon.2025.103848","DOIUrl":"10.1016/j.clon.2025.103848","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"43 ","pages":"Article 103848"},"PeriodicalIF":3.2,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143947753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Single Centre Review of the Management of Testicular Sex Cord-Stromal Cell Tumours 睾丸性索间质细胞瘤治疗的单中心综述
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-16 DOI: 10.1016/j.clon.2025.103846
C. Thompson, Z. Rajan, A. Reid, S. Hazell, E. Mayer, D. Nicol, R. Huddart
{"title":"A Single Centre Review of the Management of Testicular Sex Cord-Stromal Cell Tumours","authors":"C. Thompson,&nbsp;Z. Rajan,&nbsp;A. Reid,&nbsp;S. Hazell,&nbsp;E. Mayer,&nbsp;D. Nicol,&nbsp;R. Huddart","doi":"10.1016/j.clon.2025.103846","DOIUrl":"10.1016/j.clon.2025.103846","url":null,"abstract":"<div><h3>Aims</h3><div>Sex cord stromal cell tumours (SCSCT) are a rare subset of testicular tumours, the majority of which are benign but a small proportion can be malignant. It has been demonstrated that certain histopathological risk factors can be useful in identifying those with malignant potential. However currently the absence of pathological risk factors is not used to exclude malignancy and this study aimed to investigate whether patients with one or fewer risk factors would relapse. We aim to confirm the hypothesis that no patient with one or fewer identified pathological risk factors predicting malignancy will develop metastatic disease.</div></div><div><h3>Materials and Methods</h3><div>This was a retrospective analysis of all patients from a single centre with a diagnosis of SCSCT over a 20-year period. Cases were reviewed for the presence or absence of risk factors. Relapse rates and overall survival between the groups with and without risk factors were compared using a Kaplan-Meier analysis.</div></div><div><h3>Results</h3><div>76 SCSCTs were identified, of which 56 were deemed low-risk due to the presence of one or fewer pathological risk factors predictive of malignancy. None of the 56 patients relapsed with metastatic disease and, when compared with the 20 patients who had 2 or more risk factors for malignancy, relapse rates were significantly higher (<em>p</em> &lt; 0.0001) and overall survival lower (<em>p</em> = 0.0003) in those who had risk factors. A key limitation is our sample size.</div></div><div><h3>Conclusion</h3><div>These findings, supported by the available literature on SCSCTs, suggest that malignancy can be accurately predicted based on pathological findings. There is potential that these findings can be used to tailor follow up of low-risk patients accordingly.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"42 ","pages":"Article 103846"},"PeriodicalIF":3.2,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143922843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCR meetings 软的会议
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-16 DOI: 10.1016/S0936-6555(25)00099-8
{"title":"RCR meetings","authors":"","doi":"10.1016/S0936-6555(25)00099-8","DOIUrl":"10.1016/S0936-6555(25)00099-8","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"41 ","pages":"Article 103844"},"PeriodicalIF":3.2,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143838448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An audit of non-NHS commissioning through evaluation-funded SABR for oligometastasis: a single-network study 通过评估资助的SABR对非nhs委托的低转移的审计:一项单一网络研究
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103821
Rebecca Johnson , Philip Webb , Rebecca Muirhead
{"title":"An audit of non-NHS commissioning through evaluation-funded SABR for oligometastasis: a single-network study","authors":"Rebecca Johnson ,&nbsp;Philip Webb ,&nbsp;Rebecca Muirhead","doi":"10.1016/j.clon.2025.103821","DOIUrl":"10.1016/j.clon.2025.103821","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103821"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing lower urinary tract symptoms (LUTS) during pelvic radiotherapy: a quality improvement project 盆腔放疗期间下尿路症状的管理:一个质量改善项目
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103813
Christina Peters, Sally Appleyard
{"title":"Managing lower urinary tract symptoms (LUTS) during pelvic radiotherapy: a quality improvement project","authors":"Christina Peters,&nbsp;Sally Appleyard","doi":"10.1016/j.clon.2025.103813","DOIUrl":"10.1016/j.clon.2025.103813","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103813"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical screening accessibility for healthcare staff: an improvement project at University Hospitals Bristol and Weston NHS Foundation Trust 保健人员的子宫颈检查可及性:布里斯托尔大学医院和韦斯顿国民保健服务基金会信托基金的改进项目
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103815
Isabelle Wood, Miranda Worth, Eva Larkai, Hannah Compton, Amy Patel
{"title":"Cervical screening accessibility for healthcare staff: an improvement project at University Hospitals Bristol and Weston NHS Foundation Trust","authors":"Isabelle Wood,&nbsp;Miranda Worth,&nbsp;Eva Larkai,&nbsp;Hannah Compton,&nbsp;Amy Patel","doi":"10.1016/j.clon.2025.103815","DOIUrl":"10.1016/j.clon.2025.103815","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103815"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信